/PYC.L
PYC.L Stock - Physiomics Plc
Healthcare|BiotechnologyLSE
$0.28+0.00%
+$0.00 (+0.00%) • Dec 22
53
GoAI Score
GoAI Score
Weighted average: Momentum (25%) + Sentiment (35%) + Risk (20%) + Value (20%). ≥70 = BUY, ≤35 = SELL.HOLD
Medium Confidence
Momentum
Momentum Score
Based on price vs 50-day MA (40%), 200-day MA (40%), and MA crossover (20%). Higher = stronger uptrend.6
Sentiment
Sentiment Score
Based on analyst price target upside. 50 = neutral, 100 = very bullish (25%+ upside expected).70
Risk Score
Risk Score
Based on stock beta (volatility). Higher score = lower risk. Red (<40) = high volatility, Green (>60) = stable.86
Price Target
Price Target
Average analyst price target from the last quarter. Shows expected upside/downside from current price.+10.0%upside
Target: $0.31
AI Analysis PreviewPremium
Real-time AI-powered market analysis
Precise entry/exit price targets
Risk assessment & position sizing
Unlock GoAI Insights for PYC.L
Get institutional-grade AI analysis, real-time signals, and deep market intelligence powered by advanced machine learning.
Buy/Sell Signals
94% win rate on Alpha signals
Deep Analysis
Institutional-grade thesis
Real-Time Alerts
SMS & push notifications
Risk Scoring
Multi-factor analysis
Free 14-day trial • No credit card required
Active Trade Setup
ENTRY ZONE$0.28 – $0.29
TARGET (TP)$0.33
STOP LOSS$0.26
RISK/REWARD1:1.8
Premium members get real-time SMS alerts
Price Chart
Financial Statements
Revenue & Profitability Trend
← Swipe to see more →
Revenue
Net Income (Profit)
Net Loss
Key Metrics
Market CapN/A
P/E RatioN/A
Beta0.86
52W High$1.40
52W Low$0.25
Avg VolumeN/A
Income Statement (Fiscal Year)
| Metric | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 |
|---|---|---|---|---|---|
| Revenue | $784,005 | $543,250 | $597,354 | $830,266 | $702,314 |
| Gross Profit | $-435,077 | $-677,430 | $-581,622 | $-429,007 | $-365,785 |
| Gross Margin | -55.5% | -124.7% | -97.4% | -51.7% | -52.1% |
| Operating Income | $-457,791 | $-670,816 | $-573,733 | $-359,114 | $-337,040 |
| Net Income | $-415,254 | $-609,352 | $-477,257 | $-253,137 | $-215,827 |
| Net Margin | -53.0% | -112.2% | -79.9% | -30.5% | -30.7% |
| EPS | $-0.00 | $-0.00 | $-0.00 | $-0.00 | $-0.00 |
Company Overview
Physiomics Plc provides consulting services to pharmaceutical companies in the areas of outsourced quantitative pharmacology and computational biology in the United Kingdom, the United States, and the European Union. It offers modeling, simulation, and data analysis services covering various ranges of oncology research and development using its proprietary Virtual Tumour predictive software. The company also develops technology for use in the field of personalized medicine. Physiomics Plc was incorporated in 2001 and is based in Oxford, the United Kingdom.
Visit WebsiteLoading analyst ratings...
Earnings History & Surprises
PYC.LBeat Rate
0%
Last 0 quarters
Avg Surprise
+0%
EPS vs Estimate
Beats / Misses
0/0
Last 12 quarters
Latest EPS
$-0.00
Q1 2025
EPS Surprise History
Q2 21
No data
Q4 21
No data
Q2 22
No data
Q1 23
No data
Q3 23
No data
Q1 24
No data
Q3 24
No data
Q1 25
No data
Beat Estimate
Missed Estimate
Quarterly EPS Details
| Period | Report Date | Estimated EPS | Actual EPS | Surprise | Result |
|---|---|---|---|---|---|
Q1 2026 | Mar 4, 2026 | — | — | — | — |
Q1 2025 | Mar 5, 2025 | — | $-0.00 | — | — |
Q3 2024 | Sep 27, 2024 | — | $-0.00 | — | — |
Q1 2024 | Mar 7, 2024 | — | $-0.00 | — | — |
Q3 2023 | Sep 28, 2023 | — | $-0.00 | — | — |
Q1 2023 | Mar 7, 2023 | — | $-0.00 | — | — |
Q2 2022 | Jun 30, 2022 | — | $-0.00 | — | — |
Q4 2021 | Dec 31, 2021 | — | $-0.00 | — | — |
Q2 2021 | Jun 30, 2021 | — | $-0.00 | — | — |
Q4 2020 | Dec 31, 2020 | — | $-0.00 | — | — |
Q2 2020 | Jun 30, 2020 | — | $0.00 | — | — |
Q4 2019 | Dec 31, 2019 | — | $-0.00 | — | — |
Q2 2019 | Jun 30, 2019 | — | $-0.00 | — | — |
Q4 2018 | Dec 31, 2018 | — | $-0.00 | — | — |
Q2 2018 | Jun 30, 2018 | — | $0.00 | — | — |
Q4 2017 | Dec 31, 2017 | — | $-0.00 | — | — |
Q2 2017 | Jun 30, 2017 | — | $-0.00 | — | — |
Q4 2016 | Dec 31, 2016 | — | $-0.00 | — | — |
Q2 2016 | Jun 30, 2016 | — | $-0.01 | — | — |
Q4 2015 | Dec 31, 2015 | — | $-0.01 | — | — |
Latest News
Loading news...
Frequently Asked Questions about PYC.L
What is PYC.L's current stock price?
Physiomics Plc (PYC.L) is currently trading at $0.28 per share. The stock has moved +0.00% today.
What is the analyst price target for PYC.L?
No analyst price targets are currently available for this stock.
What sector is Physiomics Plc in?
Physiomics Plc operates in the Healthcare sector, specifically within the Biotechnology industry. The company is traded on the LSE exchange.
What is PYC.L's market cap?
Physiomics Plc has a market capitalization of $0.00 billion, making it a small-cap company.
Does PYC.L pay dividends?
No, Physiomics Plc does not currently pay a dividend to shareholders.
Similar Stocks
Healthcare SectorPOLX.L
Polarean Imaging plc
$0.08
Mkt Cap: $0.1B
ROQ.L
Roquefort Therapeutics plc
$1.30
Mkt Cap: $0.2B
TCF.L
Theracryf Plc
$0.20
Mkt Cap: $0.4B
TRLS.L
Trellus Health plc
$0.55
Mkt Cap: $0.1B
VAL.L
ValiRx plc
$0.38
Mkt Cap: $0.1B
Explore stocks similar to PYC.L for comparison